CIBC Asset Management
OCUL icon

CIBC Asset Management’s Ocular Therapeutix OCUL Stock Holding History

CIBC Asset Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.1K Hold
11,469
– – ﹤0.01% 1311
2025
Q4 		$139K Buy
+11,469
New +$139K ﹤0.01% 1271

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CIBC Asset Management's OCUL Position: Q1 2026 in Review

CIBC Asset Management held its Ocular Therapeutix (OCUL) position steady in Q1 2026 at 11,469 shares worth $97.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

CIBC Asset Management first reported a position in OCUL in Q4 2025 and has held it in 2 quarters since. The position peaked at $139K in Q4 2025. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • CIBC Asset Management held 11,469 shares of Ocular Therapeutix worth $97.1K as of Q1 2026.
  • CIBC Asset Management left its Ocular Therapeutix share count unchanged in Q1 2026.
  • Ocular Therapeutix made up ﹤0.01% of CIBC Asset Management's portfolio in Q1 2026, its #1311 holding.
  • CIBC Asset Management first reported a position in Ocular Therapeutix in Q4 2025 and has held it in 2 quarters since.
  • CIBC Asset Management's Ocular Therapeutix position peaked at $139K in Q4 2025.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.